Tag: ASX: SPL
Starpharma inks partnership to distribute VivaGel BV product in MENA region
Australian biopharmaceutical company Starpharma has secured a sales and distribution agreement for its VivaGel BV product in the Middle East and North Africa (MENA) region.
Starpharma launches R&D partnership with UQ to advance DEP cancer treatment products
Biopharmaceutical company Starpharma Holdings has ventured into a partnership with the University of Queensland’s (UQ) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub) to advance research and development on the ASX company’s targeted DEP radiotheranostic products.